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 Abstract   
Objectives: Assessment of frequency of regression and progression of mild cervical neoplasia in women positive 
for types of HPV DNA of high oncogenic potential.
Materials and methods: 111 women were studied. One-year-long observation of patients included cervical cyto-
logy, conducted every three months, and colposcopy, conducted every six months. After a period of 12 months all 
women were evaluated with colposcopy and directed biopsies of abnormal cervical 
tissue.
Results: This study conﬁ rms the signiﬁ cant eﬀ ect of age on both regression and progression of  low-grade cervical 
intraepithelial neoplasia.
Conclusions: In the age group below 26 years, complete regression of LGSIL occurs signiﬁ cantly more frequently 
than in older women.  Whereas in the over 36 age group, progression to HGSIL occurred more frequently during 
12 months of follow-up. 
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Introduction
Morbidity and mortality resulting from cervical cancer is a 
substantial social problem in Poland.  With regard to registered 
annual incidence rate, it is the second most common malignant 
cancer in women after breast cancer. Physicians diagnose cervi-
cal cancer every minute, and every two minutes one woman dies 
as a result of this disease worldwide [1].
Pre-cancerous lesion of the cervix is cervical intraepithelial 
neoplasia (CIN). Low-grade squamous intraepithelial lesion (LG-
SIL) corresponds to CIN 1, and high-grade squamous intraepithe-
lial lesion (HGSIL) histologically corresponds to CIN 2 and CIN 
3.  Diagnosis and treatment of CIN is an element of secondary 
prophylaxis and is a part of an integrated system, which purpose 
is to decrease morbidity and mortality resulting from cervical 
cancer [2].
Each year, physicians diagnose close to 1.2 million LGSIL, 
300 thousand HGSIL, and 10 thousand cases of cervical cancer 
in the United States alone [3]. Each year, in the City of Portland, 
United States, 1.2 and 1.5 per 1000 women are diagnosed with 
LGSIL and HGSIL respectively. In the age group between 25 and 
29 years, the diagnosis rate is highest and amounts to 8.1 per 
1000 patients [4]. 
The role of persistent infection with human papillomavirus 
in the process of carcinogenesis of cervical cancer has been prov-
en by multiple studies. In the year 1996, World Health Organiza-
tion recognized the infection with oncogenic types, 16 and 18, of 
HPV as a factor of human carcinogenesis. Presence of DNA HPV 
was found in 99.7% of cervical cancer cases, which confi rms the 
relationship between HPV infection and cervical intraepithelial 
neoplasia or cervical cancer [5,6,7].
Infection with HPV is mainly transmitted via sexual contact. 
More than 80% of sexually active women and men were, are, or 
will be infected with HPV in their lifetime [8]. In women below 
25 years of age most infections regress in the course of 12 to 18 
months. Persistence of infection, for a period of more than 24 
months, is usually associated with viruses of high oncogenic po-
tential. The incidence of infection with HPV decreases with age. 
However, risk of infection transformation to chronic persistent 
infection increases with age of the infected individual [9].
Objectives
Assessment of frequency of regression and progression of 
mild cervical neoplasia in women positive for types of HPV DNA 
of high oncogenic potential.
Materials and methods
One hundred eleven women diagnosed with low-grade cer-
vical intraepithelial neoplasia were studied from 2008 to 2011 
at the Laboratory of Cervical Pathophysiology, Gynecology and 
Obstetrics Clinical Hospital in Poznań. The mean age of patients 
at diagnosis was 29.2 years, median age was 27 years. The patient 
age range was 17 to 60 years. Patients were observed for a period 
of one year. Study design included cytology every three months 
and colposcopy every six months. After 12 months all patients 
had colposcopy, directed biopsies and liquid based cytology for 
molecular testing of high oncogenic HPV DNA. Every patient 
has given a written consent to the tests.
Cytological Investigations:  Cells were sampled from ecto-
cervix and endocervix using cervex-brush. Prepared slides were 
examined under optic microscope, Axiolab (Zeiss), using 200 and 
400 times magnifi cation. The specimens were classifi ed accord-
ing to The Bethesda System. The results were recorded by cyto-
technician, supervised by a cytotechnician with ten years of expe-
rience. Every tenth normal specimen with respect to cyto-onco-
logic changes was subjected to a repeat evaluation conducted by 
a more experienced cytotechnician. All specimens, classifi ed as 
abnormal with respect to cyto-oncologic changes, were subjected 
to a repeat evaluation by a pathologist. Such an evaluation sche-
matic of cytologic specimens is consistent with principles applied 
in mass prevention of cervical cancer programs used worldwide. 
Virological Investigations: The test material was obtained, 
using a cervex-brush, from the external os of the cervix and vagi-
nal wall.  The obtained specimen was placed into a liquid-based 
medium, ThinPrep PreserCyt Solution (Cytyc Corporation), and 
stored at temperature of +2 to +8°C.  The specimens were further 
treated in Laboratory of Pathophysiology of Uterine Cervix.
In the study, molecular test PCR - Amplicor HPV Roche Di-
agnostics, which identifi es the presence of one or more of the 13 
oncogenic types of human papillomavirus, was employed.  
 Streszczenie   
Cel pracy: Ocena częstotliwości regresji oraz progresji śródnabłonkowej neoplazji szyjki macicy niskiego stopnia 
– LGSIL u kobiet z pozytywnym wynikiem testumolekularnego identyﬁ kującego DNA wysoce onkogennych typów 
wirusa brodawczaka ludzkiego.
Materiał i metoda: Cała grupa badana licząca 111 kobiet z rozpoznaniem histopatologicznym LGSIL została 
poddana rocznej obserwacji cytologicznej, wykonywanej co trzy miesiące oraz kolposkopowej, wykonywanej co 6 
miesięcy. Po okresie 12 miesięcy u wszystkich pacjentek wykonano badanie kolposkopowe połączone z biopsją 
celowaną zmian szyjki macicy. 
Wyniki: Zaobserwowano znaczący wpływ wieku na odsetek kobiet, u których dochodzi do regresji bądź progresji 
zmian o charakterze śródnabłonkowej neoplazji szyjki macicy niskiego stopnia – LGSIL.
Wnioski: W grupie kobiet poniżej 26 roku życia całkowita regresja zmian typu LGSIL występuje znacznie częściej, 
a w populacji kobiet powyżej 36 roku życia w czasie rocznej obserwacji częściej dochodzi do progresji w kierunku 
zmian typu HGSIL.
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Amplicor HPV test is a quality test. It serves to identify high-
risk HPV DNA of the following genotypes: 16, 18, 31, 33, 35, 39, 
45, 51, 52, 56, 58, 59 and 68, in vitro. Positive test in molecular 
test PCR - Amplicor HPV Roche Diagnostics confi rms the pres-
ence of DNA of at least one of the 13 oncogenic types of human 
papillomavirus in the collected specimens.  
Simultaneously, isolation and amplifi cation of β-globin gene 
provides expert analysis of the number of cells and inhibition re-
actions in every tested specimen.  Amplicor HPV Roche Diag-
nostics is the only available test that is PCR based technique with 
a certifi cate of reproducibility, CE marking, in in vitro medical 
diagnostics. 
Colposcopic Investigations:  In the study, stereoscopic col-
poscope (Olympus OCS-500) was used.  Three to fi ve percent 
acetic acid and Schiller’s test were used to stain the cervix dur-
ing colposcopy evaluation. Colposcopic images were evaluated 
based on eight point Reid’s Colposcopic Index (RCI), evaluating 
lesion margin, acetowhite epithelium after staining with acetic 
acid, iodine-negative areas, and atypical vessels.  Abnormal re-
sult was defi ned as three or higher out of eight RCI.
Histopathologic Investigations:  All patients had colposco-
py-directed biopsies of abnormal cervical tissue and endocervi-
cal curettage. Indication for a histopathological verifi cation was 
primarily an abnormal pap smear. All histopathologic specimens 
were subjected to an evaluation in the Laboratory of Pathomor-
phology at the Gynecology and Obstetrics Clinical Hospital in 
Poznan. 
Statistical Investigation:  Statistical analysis included 111 
patients with diagnosis of LGSIL and positive molecular test that 
identifi ed DNA types of human papillomavirus of high oncogen-
ic potential.  Calculations, as well as graphic analysis, of results 
were conducted using Microsoft Offi ce program - Excel 2010.
Results
Out of 111 patients participating in this study, 38 (34%) pa-
tients showed lesion regression confi rmed by histopathological 
fi ndings after 12 months of follow-up. In the case of 45 (41%) 
patients, initially diagnosed with LGSIL, abnormalities persisted 
at the same level. In the remaining 28 (25%) patients progression 
of lesion to HGSIL was observed. (Figure 1). It is worth noting 
that, none of the patients developed invasive cervical cancer.
In the age group below 26 years, histopathology confi rmed 
lesion regression was observed in 21 (51%) patients after one 
year. In 12 (29%) patients, diagnosed with CIN 1, the degree 
of intraepithelial neoplasia persisted at the same level. In eight 
(20%) other patients under 26 years, cervical neoplasia pro-
gressed to HGSIL. (Figure 2).
In the age group between 26 and 35, histopathology con-
fi rmed lesion regression was observed in 17 (32%) patients after 
one year of observation. In 23 (43%) patients, initially diagnosed 
with LGSIL, the degree of intraepithelial neoplasia persisted at 
the same level. In the remaining 13 (25%) patients in this age 
group, lesion progression to HGSIL was observed. (Figure 3).
 
Figure 1. Assessment of frequency of regression and progression of mild cervical 
intraepithelial neoplasia – LGSIL in HPV DNA HR positive women.
Figure 2. Assessment of frequency of regression and progression of mild cervical 
intraepithelial neoplasia – LGSIL in HPV DNA HR positive women under the age of 26. 
Figure 3. Assessment of frequency of regression and progression of mild cervical 
intraepithelial neoplasia – LGSIL in HPV DNA HR positive women between the age of 
26 and 35.
Figure 4. Assessment of frequency of regression and progression of mild cervical 
intraepithelial neoplasia – LGSIL in HPV DNA HR positive women over the age of 36.
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In the over 36 age group none of the female patients’ lesions 
regressed, which was confi rmed by histopathological tests. In the 
case of 10 (59%) patients, initially diagnosed with LGSIL, the 
degree of intraepithelial neoplasia persisted at the same level. In 
seven (41%) of the patients in this age group lesion progression 
to HGSIL was observed.  (Figure 4).
Comparisons between the three age groups show that the per-
centage of patients with either regression or progression of cer-
vical intraepithelial neoplasia is signifi cantly infl uenced by age. 
In the youngest patients, histopathology confi rmed regression of 
lesions was most prevalent – it was observed in over 50% of pa-
tients after 12 months of follow-up. In the age group between 26 
and 35 histopathology confi rmed regression was observed in over 
30% of patients after 12 months of observation.  On the other 
hand, in the older age group, seven (over 40%) of the patients’ 
lesions progressed to HGSIL. (Figure 5).
Discussion
Persistent viral infection precedes in time the development 
of cervical cancer. It takes about four to fi ve years from initial in-
fection to development of advanced cervical intraepithelial neo-
plasia. Development of cancer generally takes nine to 15 years 
from initial HPV infection [10].
Observation approach and “wait and see” strategy for a pe-
riod of 12 months results from the fact that 80% of lesions, such 
as LGSIL, are a direct consequence of incidental infection with 
HPV and along with spontaneous regression of HPV infection, 
lesions undergo spontaneous regression. Such an approach is 
particularly indicated in nulliparous women under the age of 30. 
In some research centers frequency of spontaneous regression of 
LGSIL was estimated to be almost 90% [11, 12].  Indications 
for observation of lesions characteristic of LGSIL results from 
the fact that only 15% of lesions of this type progress to HGSIL 
[13].
Pretorius et al. found that after 24 months of observation of 
LGSIL, only 47 out of 2490 patients had lesion progression to 
HGSIL and cervical cancer, which constituted 1.9% of the entire 
studied population. In the above referenced study, authors also 
observed increase in the frequency of occurrence of progression 
of LGSIL with increasing age of the women studied [14].
In teenagers and young women planning future pregnancies, 
with a diagnosis of LGSIL, Polish Gynecologic Society 
recommends pap smears once a year and in the case of an 
abnormal pap smear result, colposcopy investigation and possibly 
colposcopy-directed biopsies [13]. 
In Ostor’s publication the frequency of regression of LGSIL 
was estimated to reach 60%, in 10% progression to HGSIL oc-
curred, and in 30% cervical intraepithelial neoplasia persisted at 
the same level [15].
In our study, in the group of 111 women with histopathologi-
cal diagnosis of LGSIL, we observed signifi cant infl uence of age 
on the percentage of women, in whom either progression or re-
gression of low-grade cervical intraepithelial neoplasia occurred. 
In the age group below 26 years of age, after 12-month obser-
vation we found that 50% of LGSIL regressed, which was con-
fi rmed by histopathologic investigation. In the age group between 
26 and 35 years, regression occurred in 30% of evaluated women, 
whereas in the age group over 36 years, 40% of women showed 
progression to HGSIL. This analysis confi rms the importance of 
intensive cytological and colposcopic follow-up of low-grade 
cervical intraepithelial neoplasia for a period of 12 months.
Conclusions
In the age group below 26 years, complete regression of 
lesion of cervical intraepithelial neoplasia occurs signifi cantly 
more frequently than in older women.
Whereas in the over 36 age group, progression to CIN 2 and 
CIN 3 occurs more frequently than in younger women during 12 
months of follow-up. 
References
  1. Centrum Onkologii Instytut im. Marii Skłodowskiej Curie. Zakład Epidemiologii i Prewencji No-
wotworów Krajowy Rejestr Nowotworów – http://www.onkologia.org.pl
  2. Spaczyński M, Kędzia W, Nowak-Markwitz E. Rak szyjki macicy Proﬁ laktyka, Diagnostyka i 
Leczenie. Warszawa: PZWL Wydawnictwo Lekarskie. 2009, 57-79.
  3. Koutsky L, Galloway D, Holmes K. Epidemiology of genital human papillomavirus infection. 
Epidemiol Rev. 1988, 10, 122–163.
  4. Insinga R, Glass A, Rush B. Diagnoses and outcomes in cervical cancer screening: a population-
based study. Am J Obstet Gynecol. 2004, 191, 105-113.
  5. Kędzia W. Etiopatogeneza raka szyjki macicy. W: Ginekologia Onkologiczna. Red. Markowska 
J. Urban & Partner. 2006, 513-520.
  6. Walboomers J, Jacobs M, Marcel M,[et al.]. Human papillomavirus is a necessary cause of 
invasive cervical cancer worldwide. J Pathol. 1999, 189, 12-19.
  7. Kędzia W, Pruski D, Józeﬁ ak A, [et al.]. Genotyping of oncogenic human papilloma viruses in 
women with HG SIL diagnosis. Ginekol Pol. 2010, 81, 740-744.
  8. Rekomendacje Polskiego Towarzystwa Ginekologicznego dotyczące szczepienia przeciwko 
zakażeniom HPV. W: Rekomendacje Polskiego Towarzystwa Ginekologicznego 2006-2011.
Red. Spaczyński M. Poznań: Redakcja “Ginekologii Polskiej”. 2012, 184-191.
  9. Sriamporn S, Parkin D, Pisani P. Behavioral risk factors for cervical cancer from a prospective 
study in Khon Kaen, Northeast Thailand. Cancer Detect Prev. 2004, 28, 334-339.
10. Kędzia H, Kędzia W. Nowotwory narządów płciowych kobiety. Diagnostyka  patomorfologiczna 
postępowanie kliniczne. Wrocław: MedPharm. 2010, 178, 186, 190, 191-192, 218.
11. Syrjanen K, Kataja V, Yliskoski M, [et al.]. Natural history of cervical human papillomavirus 
lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol. 
1992, 79, 675–82.
12. Moscicki A, Shiboski S, Hills N, [et al.]. Regression of low-grade squamous intra-epithelial 
lesions in young women. Lancet. 2004, 364, 1678–83.
13. Rekomentacje Polskiego Towarzystwa ginekologicznego, Polskiego Towrzystwa Patologów 
i Centralnego Ośrodka Koordynującego Populacyjny Program Proﬁ laktyki i Wczesnego 
Wykrywania Raka Szyjki Macicy Postępowanie w przypadku stwierdzenia śródnabłonkowej 
neoplazji i raka gruczołowego szyjki macicy.. Ginekol Pol. 2009, 80, 791-794.
14. Pretorius R, Peterson P, Azizi F, Burchette R. Subsequent risk and presentation of cervical 
intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less. Am J 
Obstet Gynecol. 2006,195, 1260-1265.
15. Ostor A. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 
1993, 12, 186-92.
Figure 5. Comparison of frequency of regression and progression of mild cervical 
intraepithelial neoplasia – LGSIL in HPV DNA HR positive women in the entire study 
population, as well as in speciﬁ c age groups.  
